Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & Administrative
Others
Ratios

Molecular Partners Ag (MOLN) Consolidated Net Income (2021 - 2025)

Historic Consolidated Net Income for Molecular Partners Ag (MOLN) over the last 5 years, with Q3 2025 value amounting to -$14403.4.

  • Molecular Partners Ag's Consolidated Net Income fell 1006.35% to -$14403.4 in Q3 2025 from the same period last year, while for Sep 2025 it was $12.9 million, marking a year-over-year increase of 10007.12%. This contributed to the annual value of -$61.4 million for FY2024, which is 1208.85% up from last year.
  • Molecular Partners Ag's Consolidated Net Income amounted to -$14403.4 in Q3 2025, which was down 1006.35% from $4.7 million recorded in Q2 2025.
  • In the past 5 years, Molecular Partners Ag's Consolidated Net Income ranged from a high of $165.2 billion in Q1 2022 and a low of -$18.2 billion during Q1 2024
  • In the last 5 years, Molecular Partners Ag's Consolidated Net Income had a median value of -$16136.5 in 2025 and averaged $8.9 billion.
  • As far as peak fluctuations go, Molecular Partners Ag's Consolidated Net Income skyrocketed by 90218183697.23% in 2022, and later crashed by 26066.73% in 2023.
  • Quarter analysis of 5 years shows Molecular Partners Ag's Consolidated Net Income stood at $51.7 billion in 2021, then tumbled by 99.76% to $122.2 million in 2022, then tumbled by 100.77% to -$934828.2 in 2023, then soared by 981.48% to $8.2 million in 2024, then crashed by 100.17% to -$14403.4 in 2025.
  • Its last three reported values are -$14403.4 in Q3 2025, $4.7 million for Q2 2025, and -$16136.5 during Q1 2025.